Baricitinib vs Metformin

Baricitinib vs Metformin: Overview

This comparison examines the pharmacological differences between Baricitinib and Metformin.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Metformin — 4-9 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Metformin — C4H11N5.

Molecular Weight: Baricitinib — 371.4170 g/mol; Metformin — 129.1640 g/mol.

Type: Baricitinib — Small molecule; Metformin — Small molecule.